Role of sphingolipids in the transport of prosaposin to the lysosomes.
Prosaposin is the precursor of four lysosomal saposins that promote the degradation of glycosphingolipids (GSLs) by acidic hydrolases. GSLs contain a hydrophobic ceramide moiety, which acts as a membrane anchor, and a hydrophilic oligosaccharide chain that faces the lumen of the Golgi apparatus and extracellular spaces. By using fumonisin B1, PDMP and D609, we tested the hypothesis that sphingolipids mediate the transport of prosaposin to the lysosomes. Fumonisin B1 interferes with the synthesis of ceramide, PDMP blocks the formation of glucosylceramide and D609 blocks the formation of sphingomyelin. Fumonisin B1 produced a 59;-85% decrease in the density of gold particles in the lysosomes of CHO and NRK cells immunolabeled with anti-prosaposin antibody, and a 55% reduction in the lysosomes of CHO cells stably transfected with an expression vector containing a human prosaposin cDNA. To examine whether the mannose 6-phosphate receptor pathway was affected by this treatment, NRK and CHO cells treated or not with fumonisin B1 were labeled with anti-cathepsin A antibody. The results showed no significant differences in labeling of the lysosomes, suggesting that the effect of fumonisin B1 was specific. When fumonisin B1 and D609 were added to the media of transfected CHO cells, a decrease in immunofluorescence with anti-prosaposin antibody was observed by confocal microscopy. PDMP did not cause any reduction in immunoreactivity, indicating that sphingolmyelin appears to be involved in this process. In conclusion, our data support the hypothesis that sphingolipids, possibly sphingomyelin, are involved in the transport of prosaposin to the lysosomes.
Lefrancois
S
S
Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada.
Michaud
L
L
Potier
M
M
Igdoura
S
S
Morales
C R
CR
D000818:Animals; D001693:Biological Transport, Active; D015415:Biomarkers; D001952:Bridged-Ring Compounds / Q000494:pharmacology; D016466:CHO Cells; D002264:Carboxylic Acids / Q000494:pharmacology; D002460:Cell Line; D006224:Cricetinae; D004791:Enzyme Inhibitors / Q000494:pharmacology; D037341:Fumonisins; D006023:Glycoproteins / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008247:Lysosomes / Q000378:metabolism*; D018613:Microscopy, Confocal; D016253:Microscopy, Immunoelectron; D009025:Morpholines / Q000494:pharmacology; D009636:Norbornanes; D010088:Oxidoreductases / Q000037:antagonists & inhibitors; D011498:Protein Precursors / Q000235:genetics / Q000378:metabolism*; D051381:Rats; D049231:Saposins; D013107:Sphingolipids / Q000378:metabolism*; D013859:Thiocarbamates; D013871:Thiones / Q000494:pharmacology; D014162:Transfection
D015415:Biomarkers; D001952:Bridged-Ring Compounds; D002264:Carboxylic Acids; D004791:Enzyme Inhibitors; D037341:Fumonisins; D006023:Glycoproteins; D009025:Morpholines; D009636:Norbornanes; C483345:PSAP protein, human; D011498:Protein Precursors; C483347:Psap protein, rat; D049231:Saposins; D013107:Sphingolipids; D013859:Thiocarbamates; D013871:Thiones; C056933:fumonisin B1; C046498:tricyclodecane-9-yl-xanthogenate; C033110:RV 538; D010088:Oxidoreductases; C108138:dihydroceramide desaturase